DUBLIN - December 17, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug Administration (FDA) approval of the InterStim (TM) smart programmer for use with the InterStim system, which ...

The FDA has approved an app-based smart programming device used to discreetly and easily control implants treating for overactive bladder (OAB), chronic fecal incontinence (FI) and non-obstructive ...

Medtronic announced approval from the U.S. Food and Drug Administration for the InterStim Micro neurostimulator on August 3, 2020, and CE Mark on January 13, 2020.“SNM therapy is already proven ...

DUBLIN, Feb. 22, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it received approval from the U.S. Food and Drug Administration (FDA) for ...

--Medtronic plc, the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration for its InterStim™ Micro neurostimulator ...

"Our updated InterStim SureScan MRI labeling means the best choice in SNM therapy keeps getting better," said Brooke Story, president, Pelvic Health & Gastric Therapies, which is reported as part ...

That would make it the world’s smallest rechargeable neurostimulator in the field, Medtronic claims, and 80% smaller than the medtech giant’s 14-cc InterStim II, a market leader since 2006.

Medtronic has treated more than 300,000 patients with recharge-free InterStim systems and, now, the rechargeable InterStim Micro and SureScan leads for the InterStim Micro and InterStim II systems ...

Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...

Axonics is still neck-and-neck with Medtronic in the sacral neuromodulation space. The company anticipates receiving the FDA’s approval for its own recharge-free implant later this year.

DUBLIN - December 17, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug Administration (FDA) approval of the InterStim (TM) smart programmer for use with the InterStim system, which ...

--Medtronic plc, the global leader in medical technology, today announced it has received approval from the United States Food and Drug Administration for expanded MRI labeling of its InterStim ...